Pamelor: Uses, dosage, side effects, warnings & patient reviews

What is Pamelor (Nortriptyline)?

Pamelor is a tricyclic antidepressant (TCA) prescribed for the treatment of major depressive disorder. Its active ingredient, nortriptyline, works by modulating the levels of certain neurotransmitters in the brain, primarily norepinephrine and serotonin.

While its primary FDA-approved use is for depression, nortriptyline is also commonly prescribed by physicians for other conditions, such as certain types of chronic pain and migraine prevention. As with all medications for depression, it requires a thorough medical evaluation and ongoing supervision.

Mechanism of Action

Pamelor (nortriptyline) is believed to exert its antidepressant effect by inhibiting the reuptake of norepinephrine and, to a lesser extent, serotonin at nerve endings. This action increases the concentration of these neurotransmitters in the synaptic cleft, which is associated with mood regulation.

Brand and Generic

Pamelor is the brand name for nortriptyline hydrochloride. Generic nortriptyline is widely available and contains the same active ingredient. For more information on the safety and equivalence of generic medications, you can read our dedicated resource.

How to Take Pamelor

Pamelor must be taken exactly as prescribed by a healthcare provider. Dosage is individualized based on the patient’s condition and response to treatment.

Administration Guidelines

• Dosage Form: Pamelor is available as capsules (10 mg, 25 mg, 50 mg, 75 mg) and as an oral solution.
• Typical Starting Dose: For depression in adults, therapy is often initiated at a low dose, such as 25 mg taken one to four times daily. The dose is gradually increased as needed and tolerated.
• Maintenance Dose: The usual effective maintenance dose ranges from 75 mg to 100 mg per day, administered in divided doses or as a single daily dose at bedtime.
• Timing: Due to its potential to cause drowsiness, taking the majority or the entire dose at bedtime may be recommended to manage this side effect and improve adherence.

Important Precautions

• Consistency: Take Pamelor at the same time(s) each day to maintain a steady level in your bloodstream.
• Duration: Do not stop taking Pamelor abruptly or change your dose without consulting your doctor, as this can lead to withdrawal symptoms or a return of depression.
• Monitoring: Your doctor may periodically check your blood level of nortriptyline to ensure it is within the therapeutic range and to guide dosing.

Side Effects of Pamelor

All medications can cause side effects. The following table categorizes potential side effects associated with Pamelor (nortriptyline) based on their general frequency. This is not a complete list.

What is Pamelor Used For?

FDA-Approved Use

Pamelor (nortriptyline) is indicated by the U.S. Food and Drug Administration (FDA) for the treatment of symptoms of depression (major depressive disorder).

Common Off-Label Uses

Under the direction of a physician, nortriptyline is also frequently prescribed for conditions beyond its official labeling. These uses are based on clinical experience and evidence but are not FDA-approved for Pamelor specifically. They include:

• Chronic Pain Management: Particularly neuropathic pain conditions, such as diabetic neuropathy or post-herpetic neuralgia.
• Migraine Prophylaxis: Used to reduce the frequency and severity of migraine headaches.
• Other Conditions: May include certain anxiety disorders, bedwetting (enuresis) in children, and smoking cessation adjunct therapy.

It is critical that patients understand these are off-label uses and should only be pursued under close medical supervision with a clear understanding of the risks and benefits.

Important Safety Concerns and Considerations

Cardiovascular Effects

Tricyclic antidepressants, including Pamelor, can affect the heart. They can cause tachycardia (fast heart rate), postural hypotension (a drop in blood pressure upon standing), and prolongation of the cardiac conduction time. For this reason, Pamelor is contraindicated during the acute recovery phase after a myocardial infarction. It should be used with great caution in patients with a history of cardiovascular disease, conduction abnormalities, or stroke.

Narrow Therapeutic Index and Overdose Risk

Pamelor has a narrow therapeutic index, meaning the difference between a therapeutic dose and a toxic dose is small. Overdose is particularly dangerous and can be fatal, causing severe cardiac arrhythmias, seizures, and coma. It is imperative that the medication be stored securely out of reach of children and others. For critical information on preventing accidental overdose, please review our guide for parents and carers.

Anticholinergic Effects

The anticholinergic properties of Pamelor are responsible for many of its common side effects (dry mouth, constipation, blurred vision, urinary retention). These effects can be problematic for certain populations:

• Elderly: Can worsen or unmask cognitive impairment.
• Men with BPH: Urinary retention can be severe. Men with known prostate enlargement (BPH) should use this medication with caution.
• People with glaucoma: Can precipitate an acute attack of angle-closure glaucoma.

Critical Warnings for Pamelor Use

Suicidality and Antidepressant Drugs

Pamelor carries a Black Box Warning, the FDA’s strongest safety alert. Antidepressants increased the risk of suicidal thinking and behavior (suicidality) in short-term studies of children, adolescents, and young adults with major depressive disorder and other psychiatric disorders. Patients of all ages started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior, especially during the initial few months of therapy and after dose changes.

Monoamine Oxidase Inhibitor (MAOI) Interaction

Pamelor must not be used concomitantly with an MAOI or within 14 days of stopping an MAOI. Initiating an MAOI after stopping Pamelor requires a washout period of at least 14 days. Combining these drugs can lead to a hypertensive crisis involving severe hyperthermia, rigidity, myoclonus, autonomic instability, and death.

Screening for Bipolar Disorder

Pamelor is approved for treating episodes of depression. It can potentially precipitate a manic or mixed episode in patients with undiagnosed bipolar disorder. Before initiating treatment, patients should be adequately screened for bipolar disorder. A family history of bipolar disorder, suicide, or depression is a significant risk factor.

Discontinuation Syndrome

Abrupt discontinuation of Pamelor after prolonged use can lead to withdrawal symptoms such as nausea, headache, malaise, and sleep disturbances. To prevent this, the dose should be tapered gradually under a doctor’s supervision when discontinuing treatment.

Pamelor Dosage Information

Dosing is highly individualized. The following table provides general guidelines for the treatment of depression in adults. All dosing must be determined and supervised by a prescribing physician.

Important Administration Notes

• Plasma level monitoring may be useful for optimizing therapy, with a suggested therapeutic window of 50-150 ng/mL for nortriptyline.
• Due to its long half-life, steady-state blood levels are achieved after approximately one week of consistent dosing at a given dose.
• For patients with hepatic impairment, dosage reduction is necessary.

Drug Interactions with Pamelor

Pamelor (nortriptyline) interacts with many medications. The table below lists some of the most significant interactions. This is not an exhaustive list.

Additional Information

Storage and Handling

Store Pamelor capsules and oral solution at room temperature (68°F to 77°F or 20°C to 25°C), in a tightly closed container, and away from light, excess heat, and moisture. Keep all medications out of the reach of children and pets, as overdose can be fatal.

Overdose Information

Nortriptyline overdose is a medical emergency. Symptoms are severe and can include confusion, agitation, hallucinations, extremely high fever, stiff muscles, fast or irregular heartbeat, seizures, and coma. If an overdose is suspected, call your local poison control center (1-800-222-1222 in the U.S.) or emergency services (911) immediately. Do not induce vomiting unless instructed by medical personnel.

Reporting Side Effects

You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA). Visit FDA MedWatch or call 1-800-FDA-1088. Reporting helps the FDA monitor drug safety and identify new risks.

References and Medical Sources

The information on this page is based on authoritative medical sources and prescribing information.

1. U.S. Food and Drug Administration (FDA). Pamelor (nortriptyline hydrochloride) Capsules Prescribing Information. [Revised 2009]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf
2. MedlinePlus. Nortriptyline. U.S. National Library of Medicine; [Updated 2022]. https://medlineplus.gov/druginfo/meds/a682620.html
3. American Psychiatric Association (APA). Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition. 2010.
4. Micromedex® (IBM Watson Health). Nortriptyline Drug Summary. [Updated periodically]. Greenwood Village, Colorado, USA.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.